Clinical Trials Sponsored by Quebec Heart Institute

Total 5038 results

National Heart Institute, Egypt

Unknown

Echocardiographic Left Atrial Function Assessment and Atrial Fibrillation Post-Coronary Artery Bypass Surgery

Atrium; Fibrillation

Egypt
Minneapolis Heart Institute Foundation

Completed

Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures (Dinosur)

Implantable Cardioverter-Defibrillators

United States
National Heart Institute, Egypt

Unknown

Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome

Diaphragm Disease

Egypt
Minneapolis Heart Institute Foundation

Completed

Endovascular Aneurysm Repair (EVAR) Gate Study (EVAR)

Abdominal Aortic Aneurysm (AAA)

United States
Baker Heart Research Institute

Unknown

Cortisol and Nutritional Sympathetic Responsiveness

Obesity | Metabolic Syndrome | Insulin Resistance

Australia
Baker Heart Research Institute

Unknown

The Effects of Weight Loss on Neuroadrenergic Function

Obesity | Metabolic Syndrome | Type 2 Diabetes

Australia
National Heart Institute, Mexico

Completed

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

Coronary Heart Disease | Hyperlipidemia

Mexico
German Heart Institute
Novartis

Unknown

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Coronary Artery Disease | Coronary Restenosis

Germany
Minneapolis Heart Institute Foundation

Recruiting

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Heart Attack | Enlarged Heart

United States
Minneapolis Heart Institute Foundation

Recruiting

Progress Bifurcation Global Registry

Coronary Artery Disease | Coronary Bifurcation Lesions

United States
Leipzig Heart Institute GmbH

Not yet recruiting

Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death

Myocardial Infarction | Sudden Cardiac Death
Minneapolis Heart Institute Foundation

Recruiting

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO)

Coronary Artery Disease

United States, Canada, Egypt, Greece, Lebanon, Russian Federation
InCor Heart Institute
Novartis

Completed

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Tuberous Sclerosis | Angiomyolipoma | Lymphangioleiomyomatosis

Brazil
Minneapolis Heart Institute Foundation

Active, not recruiting

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial (DESIFOR)

Cardiovascular Diseases | Cardiovascular Risk Factor | Adverse Effect

United States
Leipzig Heart Institute GmbH

Completed

Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation (CHOICE-CLOSURE)

Aortic Valve Stenosis

Germany
Leipzig Heart Institute GmbH

Completed

Fasting Versus Non-Fasting for Cardiac Implantable Electronic Devices (FastCIED Study)

Cardiac Implantable Electronic Devices

Germany
National Heart Institute, Mexico

Unknown

Prevention of Radial Artery Occlusion: Comparison of Three HEmostatiC Methods in Transradial Intervention (PROTHECT)

Complication | Occlusion of Artery | Radial Artery Injury

Mexico
Florida Heart Research Institute

Terminated

Study of Hispanics to Assess Risk Prevention in Prehypertension (SHARPP)

Pre-Hypertension

United States
Montreal Heart Institute
AstraZeneca

Completed

A Pharmacogenomic Study of Candesartan in Heart Failure

Heart Failure

Canada
National Heart Institute, Mexico

Completed

Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients

Acute Renal Failure | Contrast Induced Nephropathy

Mexico
Montreal Heart Institute
Pfizer

Terminated

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

Hypertension

Canada
Minneapolis Heart Institute Foundation

Not yet recruiting

Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity

Chronic Total Occlusion | Occlusion

United States
Minneapolis Heart Institute Foundation

Recruiting

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

Percutaneous Coronary Intervention | Target Vessel Failure in Saphenous Vein Grafts

United States
Leipzig Heart Institute GmbH

Not yet recruiting

Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death (PROFID-Reduced)

Myocardial Infarction | Heart Failure | Sudden Cardiac Death
Minneapolis Heart Institute Foundation

Recruiting

Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease

Aortic Valve Stenosis | Disparities in Treatment of Aortic Valve Stenosis

United States
Minneapolis Heart Institute Foundation

Recruiting

Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) (REBIRTH)

Patient Satisfaction | Vascular Access Complication

United States
Montreal Heart Institute
Servier

Active, not recruiting

Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)

Valvular Heart Disease | Atrial Fibrillation and Flutter

Canada
Minneapolis Heart Institute Foundation

Withdrawn

The SHINE-CTO Trial (SHINE-CTO)

Coronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Percutaneous Transluminal Coronary Angioplasty
National Heart Institute, Egypt

Completed

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Pneumonia
Arizona Heart Institute
Endologix

Unknown

Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study

Aortic Aneurysm

United States
Vietnam National Heart Institute

Completed

Intervention Study on Hypertension Management Combined With Health Promotion at Commune Level

Hypertension | Cardiovascular Risk Factor | Lifestyle

Vietnam
Montreal Heart Institute
Organon

Completed

Cardiac Surgery: In Vivo Titration of Protamine (Protamine)

Bleeding

Canada
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Montreal Heart Institute
Pfizer

Completed

Management With Accupril Post Bypass Graft

CABG
Montreal Heart Institute
Canadian Institutes of Health Research (CIHR); St. Justine's Hospital; Fonds...

Completed

Inhaled Milrinone in Cardiac Surgery

Pulmonary Hypertension

Canada
Baker Heart Research Institute
National Heart Foundation, Australia

Unknown

Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity

Metabolic Syndrome

Australia
The George Institute
Heart Research Institute

Recruiting

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (STARS)

Acute Ischemic Stroke

Australia
McGill University
Institut National du Sport du Quebec; Apexk

Terminated

Correlation Between Changes in Measures of the Visual System and Changes in Concussion-associated Symptoms

Concussion; Syndrome

Canada
Queen Saovabha Memorial Institute

Recruiting

Effect of ERIG Injection on Day 7 After First Dose of Rabies Vaccination to Rabies Immune Response

Rabies

Thailand
Queen Saovabha Memorial Institute

Completed

Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG

Rabies

Thailand
Queen Saovabha Memorial Institute

Completed

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

Rabies

Thailand
Queen Saovabha Memorial Institute

Completed

Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination

HIV | Rabies

Thailand
Queen Saovabha Memorial Institute

Unknown

Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors

Measles

Thailand
Minneapolis Heart Institute Foundation
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)

Acute Myocardial Infarction

United States
George Thanassoulis
Jewish General Hospital; Laval University; Quebec Heart Institute

Withdrawn

Early Aortic Valve Lipoprotein(a) Lowering Trial (EAVaLL)

Aortic Stenosis and Lipoprotein(a) Levels

Canada
Queen Saovabha Memorial Institute

Completed

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

Rabies

Thailand
Queen Saovabha Memorial Institute

Completed

Two-site Intradermal Influenza Vaccination in Elderly

Influenza

Thailand
Queen Saovabha Memorial Institute

Completed

Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV

Efficacy of the New CPRV

Thailand
Louis Bherer
Mitacs; Université de Montréal; Fonds de la Recherche en Santé du Québec

Not yet recruiting

Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults (HeART-BRAIN)

Aging | Atrial Fibrillation Recurrent

Canada
Leipzig Heart Institute GmbH
Heart Center Leipzig - University Hospital

Completed

Reducing Recurrence of Symptomatic Atrial Fibrillation After Catheter Ablation by App-based Mental Training (Mental-AF)

Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Meditation

Germany

Clinical Trials Sponsored by Quebec Heart Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations